Details of the Drug Reposition

General Information of This Drug (ID: DMPWB7T)

• Drug Name: Maprotiline (DMPWB7T)
• Synonyms: Deprilept; Dibencycladine; Maprotilin; Maprotilina; Maprotilinum; Maprotylina; Maprotylina [Polish]; TBB066626; BA-34276; Deprilept (TN); Ludiomil (TN); Maprotilina [INN-Spanish]; Maprotiline (USAN); Maprotilinum [INN-Latin]; Psymion (TN); Ba-34,276; Maprotiline [USAN:BAN:INN]; N-Methyl-9,10-ethanoanthracene-9(10H)-propanamine; N-Methyl-9,10-ethanoanthracene-9(10H)-propylamine; 3-(9,10-Dihydro-9,10-ethanoanthracen-9-yl)propylmethylamine; 3-(9,10-ethanoanthracen-9(10H)-yl)-N-methylpropan-1-amine
• Therapeutic Class: Antidepressants
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

1 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Depression	DIS3XJ69	6A70-6A7Z	Approved	[1]

1 Investigative Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Mixed anxiety and depressive disorder	DISV809X	N.A.	Investigative	[1]

References

• [1] Maprotiline FDA Label